BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8341216)

  • 21. The role of preoperative chemotherapy in the treatment of infantile fibrosarcoma.
    Kurkchubasche AG; Halvorson EG; Forman EN; Terek RM; Ferguson WS
    J Pediatr Surg; 2000 Jun; 35(6):880-3. PubMed ID: 10873030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infantile fibrosarcoma treated with postoperative vincristine and dactinomycin.
    Yoshihara H; Yoshimoto Y; Hosoya Y; Hasegawa D; Kawano T; Sakoda A; Okita H; Manabe A
    Pediatr Int; 2017 Mar; 59(3):371-374. PubMed ID: 28317309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pilot study of cyclophosphamide-doxorubicin-vincristine-cisplatin-etoposide hybrid chemotherapy in small cell lung cancer.
    Ohnoshi T; Hiraki S; Ueoka H; Kiura K; Kamei H; Horiguchi T; Kodani T; Maeda T; Tabata M; Shibayama T
    Cancer; 1993 Sep; 72(5):1597-601. PubMed ID: 8394202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Preoperative adjuvant therapy for primary malignant bone tumors].
    Goto T; Okuma T; Nakada I; Hozumi T; Kondo T
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1750-4. PubMed ID: 18030009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapeutic effect of adjuvant combination chemotherapy in the treatment of 8 cases of childhood soft-tissue sarcoma].
    Imashuku S; Todo S; Esumi N; Yamanaka H; Iwasaku M; Morioka Y; Ogita S; Tokiwa K; Fukumochi Y; Fujita K
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1063-8. PubMed ID: 3566303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR; Nejad B
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Intensive chemotherapy for alveolar soft part sarcoma with lung metastasis in a child].
    Hibi S; Naya M; Takaya K; Morimoto M; Kataoka Y; Todo S; Imashuku S
    Gan To Kagaku Ryoho; 1993 Jul; 20(9):1249-52. PubMed ID: 8333754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Right foot congenital infantile fibrosarcoma treated only with chemotherapy.
    Demir HA; Akyüz C; Varan A; Ergen FB; Büyükpamukçu M
    Pediatr Blood Cancer; 2010 Apr; 54(4):618-20. PubMed ID: 19998472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemotherapy alone for the treatment of congenital fibrosarcoma: is surgery always needed?
    Surico G; Muggeo P; Daniele RM; Novielli C; Rigillo N; Minervini C
    Med Pediatr Oncol; 2003 Apr; 40(4):268-70. PubMed ID: 12555264
    [No Abstract]   [Full Text] [Related]  

  • 31. Early salvage therapy for germ cell cancer using high dose chemotherapy with autologous bone marrow support.
    Broun ER; Nichols CR; Turns M; Williams SD; Loehrer PJ; Roth BJ; Lazarus HM; Einhorn LH
    Cancer; 1994 Mar; 73(6):1716-20. PubMed ID: 7512438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chest wall tumors in infancy and childhood.
    Shamberger RC; Grier HE; Weinstein HJ; Perez-Atayde AR; Tarbell NJ
    Cancer; 1989 Feb; 63(4):774-85. PubMed ID: 2914283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [EMA/CO regimen for chemotherapy 24 patients with ultra high-risk gestational trophoblastic neoplasia].
    Shen T; Chen LL; Qin JL; Wang XY; Cheng XD; Xie X; Lyu WG
    Zhonghua Fu Chan Ke Za Zhi; 2018 Jun; 53(6):371-376. PubMed ID: 29961278
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of chemotherapy in pediatric pulmonary blastoma.
    Ozkaynak MF; Ortega JA; Laug W; Gilsanz V; Isaacs H
    Med Pediatr Oncol; 1990; 18(1):53-6. PubMed ID: 2152957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.
    Navid F; Santana VM; Billups CA; Merchant TE; Furman WL; Spunt SL; Cain AM; Rao BN; Hale GA; Pappo AS
    Cancer; 2006 Apr; 106(8):1846-56. PubMed ID: 16541446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84.
    Flamant F; Rodary C; Rey A; Praquin MT; Sommelet D; Quintana E; Theobald S; Brunat-Mentigny M; Otten J; Voûte PA; Habrand JL; Martelli H; Barrett A; Terrier-Lacombe MJ; Oberlin O
    Eur J Cancer; 1998 Jun; 34(7):1050-62. PubMed ID: 9849454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study.
    Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE
    J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
    Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
    J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide and actinomycin-D, added in the induction phase to vincristine, cyclophosphamide and doxorubicin, improve histologic response and prognosis in patients with non metastatic Ewing's sarcoma of the extremity.
    Ferrari S; Mercuri M; Rosito P; Mancini A; Barbieri E; Longhi A; Rimondini S; Cesari M; Ruggieri P; Di Liddo M; Bacci G
    J Chemother; 1998 Dec; 10(6):484-91. PubMed ID: 9876058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital fibrosarcoma in complete remission with Somatostatin, Bromocriptine, Retinoids, Vitamin D3, Vitamin E, Vitamin C, Melatonin, Calcium, Chondroitin sulfate associated with low doses of Cyclophosphamide in a 14-year Follow up.
    Di Bella G; Toscano R; Ricchi A; Colori B
    Neuro Endocrinol Lett; 2015; 36(8):725-33. PubMed ID: 26921571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.